CERA invites people living with inherited retinal diseases (and their parents or guardians) to share their views and opinions about new potential gene therapy treatments.
A world-leading multidisciplinary research project, investigating age-related macular degeneration and the factors that make some people more likely to lose their vision.
In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.
CERA glaucoma researcher Dr Jennifer Fan Gaskin will encourage women and girls to aspire to careers in science, technology, engineering and mathematics as part of the 2021 Superstars of STEM program.
Researchers have used gene therapy to regenerate damaged optic nerve fibres in a discovery that could help treat glaucoma, one of the world’s leading causes of blindness.
New research at the Centre for Eye Research Australia will tackle the backlog of undiagnosed and untreated eye conditions resulting from missed appointments during the COVID-19 pandemic.
CERA’s research into the effectiveness of vitamin B3 in preventing nerve cell damage in glaucoma has received a major funding boost from Glaucoma Australia.
